1. |
Byhahn C, Strouhal U, Martens S, et al. Incidence of gastrointestinal complications in cardiopulmonary bypass Patients. World J Surg, 2001, 25: 1140-1144.
|
2. |
方骏, 肖颖彬, 陈林, 等. 谷氨酰胺二肽对体外循环心脏手术患者肠粘膜屏障的保护作用. 第三军医大学学报, 2005, 27(2): 2067-2069 .
|
3. |
何桂珍. 肠道屏障功能与细菌移位. 协和医学杂志, 2012, 7(3): 260-264.
|
4. |
龙村, 邓硕增. 体外循环对消化系统的影响. 国外医学麻醉学与复苏分册, 1998, 5: 170-172.
|
5. |
张红民, 李钦传, 王永武. 体外循环对内毒素影响的实验研究. 同济大学学报, 2001, 22(4): 8-10.
|
6. |
刘大为, 主编. 实用重症医学. 第1版. 北京: 人民卫生出版社. 2010. 657-659.
|
7. |
任海波, 刘彬, 李颖, 等. 降钙素原在体外循环心脏术后早期并发症中的预测价值研究. 内科急危重症杂志, 2014, 20(4): 248-250.
|
8. |
Aydin NB, Gecrekoglu H, Aksu B, et al. Endotoxemia in coronary artery bypass surgery: comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg, 2003, 125(4): 843-848.
|
9. |
Mangi A, Christison-Lagay ER, Torchiana DF, et al. Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg, 2005, 241: 895-904.
|
10. |
Working group report. Guidelines for the evaluation of probiotics in food, joint food and agriculture organization of the United Nations and the World Health Organization. 2007.
|
11. |
孙莹杰, 曹惠鹃, 张铁铮, 等. 益生菌对体外循环后大鼠肠黏膜通透性和细菌易位的影响. 沈阳部队医药, 2010, 23(4): 224-227.
|
12. |
陈海良, 杨育林. 口服益生菌对大肠癌术后患者炎症反应及肠道屏障功能的影响. 中国中西医结合消化杂志, 2014, 2(22): 38-40.
|
13. |
Cross ML. Microbes versus microbes: immune signals generated by probiotic Lactobacilli and their roe in protection against microbial pathogens. FEMS Immunol Med Micmbiol, 2002, 34(4): 245-248.
|
14. |
王平, 兰梅. 乳果糖联合双岐菌治疗肝硬化疗效及对血清二胺氧化酶和内毒素的影响. 上海预防医学, 2014, 26(4): 219-220.
|
15. |
胡长征. 乳果糖对肝硬化患者内毒素血症的影响. 中西医结合肝病杂志, 2004, 14(4): 241-242.
|
16. |
龙村, 主编. 体外循环学. 第1版. 北京: 人民军医出版社, 2004. 49-50.
|
17. |
Tan M, Zhu JC, Du J, et al. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcome in severe traumatic brain-injured patients: a prospective randomized pilot study. Criti Care, 2011, 15(6): 290.
|
18. |
Drouault-Holowaez S, Foligne B, Dennin V, et al. Anti-inflammatory potential of the probiotic dietary supplement lactibiane tolerance: intro and in vivo considerations. Clin Nutrit, 2006, 25(6): 994-1003.
|
19. |
Morroe LE, Gogineni V, Malesker MA. Probiotic, prebiotic and synbiotic use in critically ill patients. Curr Opin Crit Care, 2012, 18(2): 186-191.
|
20. |
Petrof EO, Dhaliwal R, Manzanares W, et al. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med, 2012, 40(12): 3290-3302.
|
21. |
Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 2011, 9(11): 4827.
|
22. |
栾嵘, 唐惠林, 翟所迪. 益生菌制剂预防呼吸机相关性肺炎的系统评价. 中国医院药学杂志, 2014, 34(3): 208-215.
|
23. |
童锋, 应佑华, 郭松永, 等. 早期肠内营养联合益生菌在胃肠道创伤患者术后的应用. 中华危重症医学杂志, 2012, 5(6): 33-36.
|